Not applicableLooking for participantsNCT06820515What this trial is testingATHNdataset RegistryWho this might be right forHemophiliaThrombosisHemophilia A+6 more American Thrombosis and Hemostasis Network 200,000
Testing effectiveness (Phase 2)Ended earlyNCT00131508What this trial is testingTrial of Oral Glutamine in Patients With Sickle Cell AnemiaWho this might be right forAnemia, Sickle Cell St. Jude Children's Research Hospital 27
Not applicableStudy completedNCT00860782What this trial is testingParent Educational Program for Children With Sickle Cell DiseaseWho this might be right forHemoglobin SC DiseaseAnemia, Sickle Cell University of Miami 73
Not applicableStudy completedNCT00520559What this trial is testingT2* in Transfusion Dependant Anemia, MI, LVF, Normal PatientsWho this might be right forThalassemia Imperial College London 652
Large-scale testing (Phase 3)Study completedNCT02675790What this trial is testingModerate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan AfricaWho this might be right forSickle Cell DiseaseSickle Cell AnemiaStroke Vanderbilt University Medical Center 120
Post-approval studies (Phase 4)Looking for participantsNCT07468513What this trial is testingPrimaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.Who this might be right forVivax MalariaG6PD Deficiency Menzies School of Health Research 100
Not applicableStudy completedNCT00367523What this trial is testingPulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaWho this might be right forSecondary Pulmonary Arterial HypertensionSickle Cell DiseasePulmonary Hypertension National Heart, Lung, and Blood Institute (NHLBI) 308
Testing effectiveness (Phase 2)Ended earlyNCT01033227What this trial is testingSafety and Efficacy of Sodium Nitrite in Sickle Cell DiseaseWho this might be right forSickle Cell Disease Children's Hospital Los Angeles 5
Large-scale testing (Phase 3)Study completedNCT00235391What this trial is testingExpanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron OverloadWho this might be right forThalassemiaSickle Cell DiseaseDiamond Blackfan Anemia+1 more Novartis Pharmaceuticals 1,683
Early research (Phase 1)Study completedNCT02497924What this trial is testingThe Absorption, Metabolism, and Excretion of GBT440 in Healthy Male SubjectsWho this might be right forAnemia, Sickle Cell Global Blood Therapeutics 7
Not applicableStudy completedNCT07094646What this trial is testingFull Assessment of Clinical Transfusion SupportWho this might be right forSickle Cell AnemiaBlood TransfusionMalaria Parasitaemia Children's Hospital Medical Center, Cincinnati 250
Not applicableLooking for participantsNCT07186179What this trial is testingMobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)Who this might be right forDiamond Blackfan Anemia Northwell Health 10
Not applicableStudy completedNCT01848691What this trial is testingCarbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without HemolysisWho this might be right forSickle Cell Anemia Ashutosh Lal 40
Not applicableStudy completedNCT02829580What this trial is testingEvaluation of Non-invasive Endothelial Function in Children Sickle by Vascular UltrasoundWho this might be right forSickle Cell Disease University Hospital, Toulouse 31
Large-scale testing (Phase 3)Ended earlyNCT04218084What this trial is testingStudy to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell DiseaseWho this might be right forSickle Cell Disease Pfizer 236
Large-scale testing (Phase 3)UnknownNCT01511848What this trial is testingStudy Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron OverloadWho this might be right forBeta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis Ain Shams University 60
Testing effectiveness (Phase 2)Study completedNCT02151526What this trial is testingA Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell DiseaseWho this might be right forBeta-Thalassemia MajorSickle Cell Disease Genetix Biotherapeutics Inc. 7
Not applicableStudy completedNCT00386048What this trial is testingPain Management Protocol for Pediatric Sickle Cell DiseaseWho this might be right forSickle Cell Disease University of South Carolina 50
Not applicableStudy completedNCT02143076What this trial is testingMedication Adherence in Youth With Sickle Cell Disease (SCD)Who this might be right forSickle Cell Disease St. Jude Children's Research Hospital 36
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16